Cargando…

Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes

BACKGROUND: MUC16 is a cell surface mucin expressed at high levels by epithelial ovarian tumors. Following proteolytic cleavage, cell surface MUC16 (csMUC16) is shed in the extracellular milieu and is detected in the serum of cancer patients as the tumor marker CA125. csMUC16 acts as an adhesion mol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Belisle, Jennifer A, Horibata, Sachi, Jennifer, Gubbels AA, Petrie, Sarah, Kapur, Arvinder, André, Sabine, Gabius, Hans-Joachim, Rancourt, Claudine, Connor, Joseph, Paulson, James C, Patankar, Manish S
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2890604/ https://www.ncbi.nlm.nih.gov/pubmed/20497550 http://dx.doi.org/10.1186/1476-4598-9-118

Ejemplares similares

MUC16 provides immune protection by inhibiting synapse formation between NK and ovarian tumor cells
por: Gubbels, Jennifer AA, et al.
Publicado: (2010)

Characterization of the tumor marker muc16 (ca125) expressed by murine ovarian tumor cell lines and identification of a panel of cross-reactive monoclonal antibodies
por: Goodell, Cara AR, et al.
Publicado: (2009)

Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors
por: Gubbels, Jennifer AA, et al.
Publicado: (2006)

MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress
por: Felder, Mildred, et al.
Publicado: (2014)

The detection, treatment, and biology of epithelial ovarian cancer
por: Gubbels, Jennifer AA, et al.
Publicado: (2010)

Oxidative Phosphorylation: A Target for Novel Therapeutic Strategies Against Ovarian Cancer
por: Nayak, Amruta P., et al.
Publicado: (2018)

Siglec-7/-9 ligands shield tumor cells from NK cell attack
por: Jandus, Camilla, et al.
Publicado: (2013)

Glycocalyx Engineering Reveals a Siglec-Based Mechanism for NK Cell Immunoevasion
por: Hudak, Jason E., et al.
Publicado: (2013)

M2 macrophages induce ovarian cancer cell proliferation via a heparin binding epidermal growth factor/matrix metalloproteinase 9 intercellular feedback loop
por: Carroll, Molly J., et al.
Publicado: (2016)

MUC1 modulates the tumor immune microenvironment through the engagement of Siglec-9
por: Beatson, Richard, et al.
Publicado: (2016)

Siglec-F is a novel intestinal M cell marker
por: Gicheva, Nadezhda, et al.
Publicado: (2016)

Plumbagin-induced oxidative stress leads to inhibition of Na(+)/K(+)-ATPase (NKA) in canine cancer cells
por: Alharbi, Yousef, et al.
Publicado: (2019)

Siglec-7 expression is reduced on a natural killer (NK) cell subset of obese humans
por: Rosenstock, Philip, et al.
Publicado: (2017)

Oxidative stress induced by the anti-cancer agents, plumbagin, and atovaquone, inhibits ion transport through Na(+)/K(+)-ATPase
por: Alharbi, Yousef, et al.
Publicado: (2020)

MUC16 mucin (CA125) attenuates TRAIL-induced apoptosis by decreasing TRAIL receptor R2 expression and increasing c-FLIP expression
por: Matte, Isabelle, et al.
Publicado: (2014)

An anti-MUC1-antibody–interleukin-2 fusion protein that activates resting NK cells to lysis of MUC1-positive tumour cells
por: Heuser, C, et al.
Publicado: (2003)

Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9
por: Rodriguez, Ernesto, et al.
Publicado: (2021)

Transcriptomic profile of intrinsically chemoresistant acute myeloid leukemia patients
por: Horibata, Sachi
Publicado: (2019)

NK cells and monocytes modulate primary HTLV-1 infection
por: Moles, Ramona, et al.
Publicado: (2022)

The Roles of Siglec7 and Siglec9 on Natural Killer Cells in Virus Infection and Tumour Progression
por: Zheng, Yayun, et al.
Publicado: (2020)

Engagement of Siglec-7 Receptor Induces a Pro-Inflammatory Response Selectively in Monocytes
por: Varchetta, Stefania, et al.
Publicado: (2012)

Siglec Ligands
por: Gonzalez-Gil, Anabel, et al.
Publicado: (2021)

A Developed NK-92MI Cell Line with Siglec-7(neg) Phenotype Exhibits High and Sustainable Cytotoxicity against Leukemia Cells
por: Huang, Chin-Han, et al.
Publicado: (2018)

Molecular cloning of porcine Siglec-3, Siglec-5 and Siglec-10, and identification of Siglec-10 as an alternative receptor for porcine reproductive and respiratory syndrome virus (PRRSV)
por: Xie, Jiexiong, et al.
Publicado: (2017)

HN125: A Novel Immunoadhesin Targeting MUC16 with Potential for Cancer Therapy
por: Xiang, Xinran, et al.
Publicado: (2011)

The Role of Siglec-G on Immune Cells in Sepsis
por: Royster, William, et al.
Publicado: (2021)

Coevolution of Siglec-11 and Siglec-16 via gene conversion in primates
por: Hayakawa, Toshiyuki, et al.
Publicado: (2017)

A CRISPR activation screen identifies MUC-21 as critical for resistance to NK and T cell-mediated cytotoxicity
por: Lee, Dong-hee, et al.
Publicado: (2023)

Interplay of NK cells and monocytes in vascular inflammation and myocardial infarction
por: Knorr, Maike, et al.
Publicado: (2014)

Siglec-7 glyco-immune binding mAbs or NK cell engager biologics induce potent antitumor immunity against ovarian cancers
por: Bordoloi, Devivasha, et al.
Publicado: (2023)

Trans10,cis12 conjugated linoleic acid inhibits proliferation and migration of ovarian cancer cells by inducing ER stress, autophagy, and modulation of Src
por: Shahzad, Mian M. K., et al.
Publicado: (2018)

Monocyte Siglec-14 expression is upregulated in patients with systemic lupus erythematosus and correlates with lupus disease activity
por: Thornhill, Susannah I., et al.
Publicado: (2017)

Siglec-1 expression on monocytes is associated with the interferon signature in juvenile dermatomyositis and can predict treatment response
por: Lerkvaleekul, Butsabong, et al.
Publicado: (2021)

Sialic Acids on Tumor Cells Modulate IgA Therapy by Neutrophils via Inhibitory Receptors Siglec-7 and Siglec-9
por: Chan, Chilam, et al.
Publicado: (2023)

Modulation of oxidative stress and subsequent induction of apoptosis and endoplasmic reticulum stress allows citral to decrease cancer cell proliferation
por: Kapur, Arvinder, et al.
Publicado: (2016)

The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency
por: Bigley, Venetia, et al.
Publicado: (2011)

Sialylated keratan sulfate proteoglycans are Siglec-8 ligands in human airways
por: Gonzalez-Gil, Anabel, et al.
Publicado: (2018)

CD169/SIGLEC1 is expressed on circulating monocytes in COVID-19 and expression levels are associated with disease severity
por: Doehn, Jan-Moritz, et al.
Publicado: (2021)

Siglecs at the Host–Pathogen Interface
por: Chang, Yung-Chi, et al.
Publicado: (2020)

Siglecs as Therapeutic Targets in Cancer
por: Lim, Jackwee, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_69u7i9s5q52k3c3jhbheouehcr